ELV
Elevance Health, Inc.
Stock
$386.43+4.76 (+1.25%)Close Oct 2, 2026
Key figures
| Metric | Last 12 months | 5-year CAGR |
|---|---|---|
| Revenue | $201.1B | +10.3% |
| Operating income | $5.5B | +2.5% |
| Net income | $5.0B | +4.4% |
| EPS | $22.50 | +7.0% |
| Free cash flow | $6.3B | −20.0% |
Elevance Health, Inc.
$386.43+4.76 (+1.25%)Close Oct 2, 2026
| Metric | Last 12 months | 5-year CAGR |
|---|---|---|
| Revenue | $201.1B | +10.3% |
| Operating income | $5.5B | +2.5% |
| Net income | $5.0B | +4.4% |
| EPS | $22.50 | +7.0% |
| Free cash flow | $6.3B | −20.0% |